Black people in the US are not only more likely than other folks to get eczema in childhood, but may have harder-to-treat or ...
Sep. 19, 2023 — Adults with atopic dermatitis (AD) have a 34 percent increased risk of developing new-onset inflammatory bowel disease (IBD) compared with individuals who do not have the skin ...
A global team of researchers has made a groundbreaking discovery that saves the lives of patients suffering from toxic epidermal necrolysis. This rare but often fatal reaction to common medications ...
Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...
For the first time, researchers have created a single cell atlas of prenatal human skin to understand how skin forms, and ...
Eczematous dermatitis was the most common skin condition diagnosed in patients with Down syndrome, according to a multicenter ...
Certain conditions, such as pregnancy or Addison's disease (decreased function ... Use sunscreento reduce your risk of sun damage and skin cancer. Tinea versicolor is a common fungal skin ...
Ongoing stress can also weaken your immune system. This makes you more vulnerable to infection and skin diseases like vitiligo (loss of skin colour) and chronic urticaria (another name for hives).
Athlete’s foot, also known as tinea pedis, is a highly contagious fungal infection ... can help you avoid catching this common fungal skin infection. These fungi thrive in moist, warm environments, ...
per the Centers for Disease Control and Prevention (CDC). “Contact dermatitis is most often characterized by itching, scaly skin, small and large pink patches that occur in the areas that have contact ...
Psoriasis complications go beyond the way skin may look. You may have a wide range of other issues, like heart disease, kidney disease, joint problems, or depression, as a result of the disease.
1 "Hidradenitis suppurativa is a chronic, relapsing, and painful inflammatory skin disease that significantly impacts patients' quality of life. The bimekizumab data presented at EADV 2024 showed ...